Clincosm LogoSign in Get a demo

locally advanced esophageal squamous cell carcinoma

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Esophageal Squamous Cell Carcinoma Trial (Tiragolumab)

Not yet recruiting
  • Locally Advanced Esophageal Squamous Cell Carcinoma
  • (no location specified)
Feb 23, 2023

Locally Advanced Esophageal Squamous Cell Carcinoma Trial in Tokyo (Nivolumab, 5-FU, CDDP)

Recruiting
  • Locally Advanced Esophageal Squamous Cell Carcinoma
  • Nivolumab
  • +3 more
  • Tokyo, Japan
    National Cancer Center Hospital
Apr 5, 2022

Locally Advanced Esophageal Squamous Cell Carcinoma Trial in Zhengzhou (SHR-1210+docetaxel+nedaplatin, SHR-1210+Apatinib)

Recruiting
  • Locally Advanced Esophageal Squamous Cell Carcinoma
  • Zhengzhou, Henan, China
    The First Affiliated Hospital of Zhengzhou University
Feb 16, 2022

Locally Advanced Esophageal Squamous Cell Carcinoma Trial in Taipei (Nivolumab)

Recruiting
  • Locally Advanced Esophageal Squamous Cell Carcinoma
  • Taipei, Taiwan
    National Taiwan University Hospital
Nov 22, 2021

Locally Advanced Esophageal Squamous Cell Carcinoma Trial in Zhengzhou (Toripalimab+Nedaplatin+Albumin Paclitaxel)

Not yet recruiting
  • Locally Advanced Esophageal Squamous Cell Carcinoma
  • Toripalimab+Nedaplatin+Albumin Paclitaxel
  • Zhengzhou, Hennan, China
    The First Affiliated Hospital of Zhengzhou University
Aug 19, 2021

Locally Advanced Esophageal Squamous Cell Carcinoma Trial in Chengdu (Sintilimab, Chemotherapy, Radiation Therapy)

Unknown status
  • Locally Advanced Esophageal Squamous Cell Carcinoma
  • Chengdu, Sichuan, China
    Sichuan Cancer Hospital & Institute
Oct 23, 2020